Age Ayurveda Nighantu Ayurvedic practitioner? List or verify your practice

Haridra

Curcuma longa L.

Haridra (Curcuma longa L.) is a plant drug, also called Dosa, Ksanada and Nisa. Curcuma longa is included in WHO monographs on selected medicinal plants (Volume 1).

Key facts
Botanical nameCurcuma longa L.
FamilyZingiberaceae · other entries in this family
OrderZingiberales
Pharmacopoeia statusCurcuma longa is included in WHO monographs on selected medicinal plants (Volume 1). WHO acknowledges anti-inflammatory, antimicrobial, and wound healing properties. Listed in pharmacopoeias worldwide including USP, EP, IP, BP, and JP. GRAS status by US FDA.
Taxon identifiersGBIF 2757624 · Wikidata Q42562 · NCBI Taxonomy 136217
Names in other languages
Sanskritहरिद्रा (haridrā), Dosa, Ksanada, Nisa, रजनी (rajanī), Ratri
Hindiहल्दी (haldī), Hardi
EnglishTurmeric
Tamilமஞ்சள், Manjal
MalayalamManjal
TeluguPasupu
KannadaArishina
MarathiHalad
BengaliHalud
GujaratiHaidar
UrduHaldi
PunjabiHaidar, Haldi
OriyaHaladi
AssameseHaldhi
KashmiriLedar

Sources: Ayurvedic Pharmacopoeia of India; Ayurvedic Pharmacopoeia of India, Part I Vol I, monograph 30 HARIDRĀ (Curcuma longa Linn.), Sanskrit: Rajanī, Niśā, Niśī, Rātri, Kṣaṇadā, Doṣā; Ayurvedic Pharmacopoeia of India, Part I Vol I, monograph 30 HARIDRĀ (cured rhizomes of Curcuma longa Linn.), Hindi: Haldi, Hardi; Flowers of India (Turmeric) in Devanagari: 'Hindi: हल्दी (Haldi)'.; Ayurvedic Pharmacopoeia of India, Part I Vol I, monograph 30 HARIDRĀ, Tamil: Manjal; Flowers of India (Turmeric) in Tamil script: 'Tamil: மஞ்சள் (Manjal)'.; Ayurvedic Pharmacopoeia of India, Part I Vol I, monograph 30 is titled HARIDRĀ and defined as the rhizome of Curcuma longa Linn.; wisdomlib s.v. Haridrā quotes Monier-Williams ('Turmeric, either the plant or the powdered root') and identifies Curcuma longa L.. How we source.

The evidence at a glance

12papers on this site for this drug, published 2016 to 2025, every one with a DOI.

  • 6Systematic reviews and meta-analyses
  • 6Other clinical studies and reviews

A count is not a conclusion and a tier is a study design, not a verdict. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.

Names and identification

LanguageName
SanskritHaridra
Latin/BotanicalCurcuma longa L.

Parts Used

  • Rhizome

Dosha Effects

DoshaEffect
VataDecreases
KaphaDecreases
PittaNeutral (Decreases In Moderation)

Key Phytochemical Constituents

Therapeutic Actions (Karma)

  • Anti-inflammatory (potent COX-2 inhibitor)
  • Antioxidant
  • Hepatoprotective
  • Anti-cancer (preclinical)
  • Wound healing
  • Anti-microbial
  • Digestive

How does it work?

  • NF-kB pathway suppression: Curcumin blocks NF-kB activation by inhibiting phosphorylase kinase, suppressing 200+ genes related to inflammatory cell proliferation, cell migration, and epidermal hyperproliferation in psoriasis and dermatitis
  • Tyrosinase inhibition and MITF regulation: Curcumin suppresses melanogenesis through dual strategies - competitive tyrosinase binding to block catalytic activity AND disrupting MITF-TYR/TRP transcriptional axis for melanin synthesis inhibition
  • MMP-1/MMP-9 collagen protection via MAPK pathway: Curcumin reduces MMP-1 expression by blocking JNK and p38 phosphorylation in the MAPK signaling pathway, preventing type I collagen degradation and protecting dermal extracellular matrix
  • Wound healing fibroblast stimulation: Curcumin promotes fibroblast proliferation, enhances collagen synthesis and deposition, increases vascular density at wound sites, and modulates TGF-beta signaling for accelerated tissue repair

Which traditional uses are supported by research?

These summaries come from the source notes, which do not name the studies behind them.

  • Vranaropana (wound care): traditionally used for wounds. A scoping review of clinical trials reported faster wound closure, greater collagen deposition and increased vascular density.
  • Ekakushtha (psoriasis): traditionally used for Ekakushtha. A randomized controlled trial reported that a curcumin microemulgel improved psoriasis severity scores and quality of life.
  • Varnya (skin complexion): traditionally used for complexion. Research has reported tyrosinase inhibition and MITF regulation, with reduced melanin synthesis.
  • Anti-aging and photoprotection: research has reported reduced UV-induced photoaging, linked to MMP suppression, antioxidant protection and anti-inflammatory activity.

How is it used traditionally?

Used in many Ayurvedic formulations. Sacred in Hindu rituals. Classified as Varnya (complexion-enhancing), Kushthagna (anti-dermatosis), and Vishaghna (antitoxic). Golden milk (Haldi Doodh) is a traditional preparation.

Where is it described in the classical texts?

  • Charaka Samhita
  • Sushruta Samhita
  • Bhavaprakasha Nighantu
  • Ashtanga Hridaya

What do recent studies show?

Only studies that could be traced to a published paper are listed here. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • Topical curcumin is generally well-tolerated with minimal adverse effects; may cause temporary yellow staining of skin. The 0.5% microemulgel formulation showed excellent tolerability in clinical trials with no significant side effects
  • Major limitation is low oral bioavailability; enhanced formulations (nano-curcumin, liposomal curcumin, piperine combinations) improve absorption. Oral curcumin at high doses (>8g/day) may cause GI disturbance. GRAS status by FDA for food use

Powder and curcumin extract: at the doses given under Standard Dosage (with piperine for bioavailability).

Safety, contraindications and cautions

  • Gallstones (stimulates bile)
  • Blood thinners (anticoagulant synergy)
  • Pre-surgery
  • Iron-deficiency anemia (may reduce iron absorption)

What is it made of?

Key Active Markers

  • Curcumin
  • Demethoxycurcumin
  • Bisdemethoxycurcumin
  • Turmerone
  • Zingiberene
  • Curlone
  • Curcuminoids complex

Dosage forms and preparation

Dosage Forms: Churna (powder), Tablet, Capsule, Kashayam (decoction), Lepa (paste for external use), Taila (oil), Soft gel capsule, Nano-formulation

Standard Dosage: 1 to 3 g powder (Ayurvedic Pharmacopoeia of India, Part I, Vol. I) daily; 400-600mg curcuminoid extract twice daily; 15-30ml decoction

Optimal Timing: With meals containing fat for improved absorption; traditionally taken with warm milk or ghee at bedtime

Storage: Cool, dry place protected from light (curcumin degrades under UV). Store below 25°C in amber containers. Avoid alkaline environments.

Marker Compounds: Curcumin (diferuloylmethane), Demethoxycurcumin, Bisdemethoxycurcumin, ar-Turmerone, Turmerone, Zingiberene

Synergistic Combinations

  • With Pippali (Piper longum), which contains piperine
  • With Maricha (black pepper) for curcumin absorption
  • With Guduchi for immune modulation
  • With Neem for skin disorders
  • With Ghee or oil for lipid-mediated absorption
  • With Amalaki for antioxidant synergy

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Other clinical studies and reviews6

  1. Parvizi MM, Arefkia A, Dehghan Y and others. 2025. A Scoping Review of Clinical Trials on the Efficacy of Curcumin and Its Formulations for Wound HealingJournal of cosmetic dermatology. PMID 41388841 · doi:10.1111/jocd.70615
  2. Nie Y, Li Y. 2025. Curcumin: a potential anti-photoaging agentFrontiers in pharmacology. PMID 40395726 · doi:10.3389/fphar.2025.1559032
  3. Mo Z, Yuan J, Guan X and others. 2024. Advancements in Dermatological Applications of Curcumin: Clinical Efficacy and Mechanistic Insights in the Management of Skin DisordersClinical, cosmetic and investigational dermatology. PMID 38765192 · doi:10.2147/CCID.S467442
  4. Corrêa Carvalho G, Marena GD, Gaspar Gonçalves Fernandes M and others. 2024. Curcuma Longa: Nutraceutical Use and Association With NanotechnologyAdvanced healthcare materials. PMID 38712468 · doi:10.1002/adhm.202400506
  5. Kasprzak-Drozd K, Niziński P, Hawrył A and others. 2024. Potential of Curcumin in the Management of Skin DiseasesInternational journal of molecular sciences. PMID 38612433 · doi:10.3390/ijms25073617
  6. Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez MJ. 2023. Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A ReviewPharmaceuticals (Basel, Switzerland). PMID 37111272 · doi:10.3390/ph16040515

Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.

Available from Age Ayurveda

This encyclopedia is published by Age Ayurveda. The products below are ours, and are listed here because they contain or use what this page describes.

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.